Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Revlimid TM

Active ingredients: lenalidomide

What it is used for

Multiple Myeloma (MM) Revlimid is indicated for the treatment of patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplantation. Revlimid is indicated for the maintenance treatment of patients with newly diagnosed mulitple myeloma who have undergone autologous stem cell transplantation. Revlimid in combination with dexamethasone is indicated for the treatment of multiple myeloma patients whose disease has progressed after one therapy.,Myelodysplastic Syndromes (MDS) Revlimid is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL) Revlimid is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

  • Store below 25 degrees Celsius
  • Store in Original Container
  • Shelf lifetime is 3 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

white to off-white opaque body/ powder blue opaque cap size 0 capsules marked "15mg REV" in black

Food interactions

For the active ingredient lenalidomide

  • When given with a fatty meal, the extent of absorption is reduced.

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2019. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy?

For the active ingredient lenalidomide

This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.

Download leaflet

For side effects, taking other medicines and more

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Back to top back to top

Need more information?

These trusted information partners have more on this topic.

Top results

Deletion 5q | Leukaemia Foundation

Deletion 5q is a rare form of Myelodysplastic Syndrome (MDS).

Read more on Leukaemia Foundation website

Amyloidosis treatment | Leukaemia Foundation

How is amyloidosis treated? There is a range of treatments available for amyloidosis with much research being carried out around the world to find new treatments. Once a firm diagnosis has been made and the subtype of amyloidosis is identified, yourdoctors will discuss their recommended treatment regime with you.

Read more on Leukaemia Foundation website

AL amyloidosis | Leukaemia Foundation

AL amyloidosis was previously known as "primary systemic amyloidosis".

Read more on Leukaemia Foundation website

Side-effects of myeloma treatment | Leukaemia Foundation

All treatments can cause side-effects. However, the type and severity will vary between individuals, depending on the type of treatment used and how an individual responds to it. In general, more intensive treatment is associated with more severe side-effects. It is important to report any symptoms you are having to

Read more on Leukaemia Foundation website

Side effects of amyloidosis treatment | Leukaemia Foundation

All treatments can cause side effects. However, thetype and severity will vary between individuals, depending on the type of treatment used and how an individual responds to it. In general, more intensive treatment is associated with more severe side effects. It is important to report any symptoms you are having to

Read more on Leukaemia Foundation website

Healthdirect 24hr 7 days a week hotline

24 hour health advice you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information and advice

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo